Clincosm LogoSign in Get a demo

neoplasm

Showing NaN - NaN of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Tumors, Tumor Trial in Worldwide (BMS-986226, Nivolumab, Ipilimumab)

Completed
  • Cancer
  • +3 more
  • Boston, Massachusetts
  • +12 more
Mar 11, 2022

Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)

Completed
Has Results
  • Neoplasm
  • PF-05212384 (gedatolisib)
  • +3 more
  • Birmingham, Alabama
  • +28 more
Sep 9, 2021

Melanoma, Metastatic Melanoma, Solid Tumor Trial in United Kingdom, United States (MLN2480)

Completed
Has Results
  • Melanoma
  • +3 more
  • San Francisco, California
  • +15 more
Jul 28, 2020

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Carcinoma, Non-small-cell Lung, Metastases Trial in United States (ZD1839 (Gefitinib))

Completed
  • Carcinoma
  • +3 more
  • ZD1839 (Gefitinib)
  • Alabaster, Alabama
  • +626 more
Jan 3, 2013

Tumor Trial in Tampa, New Brunswick, Philadelphia (Liposome Entrapped Paclitaxel Easy to Use)

Completed
  • Neoplasm
  • Liposome Entrapped Paclitaxel Easy to Use
  • Tampa, Florida
  • +2 more
Jun 30, 2011